{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:53:13Z","timestamp":1793987593383,"version":"4.8.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The triglyceride-glucose index (TyG index) is one of the surrogate markers of insulin resistance, and high-sensitivity C-reactive protein (hsCRP) reflects systemic inflammation. Existing studies suggest that insulin resistance or systemic inflammation may be indicative of cardiometabolic disease, but few of the existing studies have combined the TyG index and inflammation levels before assessing cardiometabolic multimorbidity. Our study data came from the China Health and Retirement Longitudinal Study (CHARLS). Participants in this data were followed for 9 years, and we used these data to conduct a long-term analysis to assess the combined effects of the TyG index and hsCRP on cardiometabolic multimorbidity in Chinese adults over 45 years of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To study the combined effect of TyG index and hsCRP on cardiometabolic multimorbidity in middle-aged as well as elderly Chinese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The study data came from the China Health and Retirement Longitudinal Study (CHARLS), which included a total of 4,483 middle-aged and elderly participants who did not have cardiovascular metabolic diseases at baseline, which was from CHARLS 2011, and the last survey was in 2020. A total of five cardiometabolic diseases were considered in this study: diabetes, hypertension, hyperlipidemia, heart disease and stroke. A person was defined as having cardiometabolic multimorbidity when he\/she had two or more cardiometabolic diseases at the same time. TyG index (median as cut-off) and hsCRP (1mg\/L as cut-off) were each divided into two groups and combined into four groups (Group L-L: TyG index&amp;lt;median &amp;amp; hsCRP&amp;lt;1mg\/L; Group H-L: TyG index&amp;gt;=median &amp;amp; hsCRP&amp;lt;1mg\/L; Group L-H: TyG index&amp;lt;median &amp;amp; hsCRP&amp;gt;=1mg\/L; Group H-H: TyG index&amp;gt;=median &amp;amp; hsCRP&amp;gt;=1mg\/L). Multiple regression equations were fitted to analyse the combined influence of TyG index and hsCRP on cardiometabolic multimorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TyG index increases the risk of CMM events independently of hsCRP, as does the reverse. When the TyG index is elevated and hsCRP is also elevated, this condition significantly increases the danger of cardiometabolic multimorbidity in middle-aged and elderly Chinese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High levels of TyG index and hsCRP can enhance the danger of cardiometabolic multimorbidity in Chinese middle-aged and elderly people, and the joint use of hsCRP and TyG index assessment may be a better way to achieve primary prevention of cardiometabolic multimorbidity in Chinese middle-aged and elderly people.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1511319","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:16:22Z","timestamp":1743466582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity"],"prefix":"10.3389","volume":"16","author":[{"given":"Bingen","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liancheng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-024-00269-7","article-title":"Triglyceride-glucose index as predictor for hypertension, CHD and STROKE risk among non-diabetic patients: A NHANES cross-sectional study 2001-2020","volume":"14","author":"Sawaf","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1186\/s12889-024-19521-7","article-title":"Association between muscle strength and cardiometabolic multimorbidity risk among middle-aged and older Chinese adults: a nationwide longitudinal cohort study","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1381949","article-title":"The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study","volume":"15","author":"Ye","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jad.2023.04.048","article-title":"Depressive symptoms and risk of incident cardiometabolic multimorbidity in community-dwelling older adults: The China Health and Retirement Longitudinal Study","volume":"335","author":"Wang","year":"2023","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3390\/nu13103419","article-title":"Alcohol\u2019s impact on the cardiovascular system","volume":"13","author":"Roerecke","year":"2021","journal-title":"Nutrients"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.322000","article-title":"Molecular biomarkers for cardiometabolic disease: risk assessment in young individuals","volume":"132","author":"Tahir","year":"2023","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.3390\/ijms21124314","article-title":"The role of estrogen receptors in cardiovascular disease","volume":"21","author":"Aryan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029386","article-title":"Long-term cumulative high-sensitivity C-reactive protein and mortality among patients with acute heart failure","volume":"12","author":"Zhang","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jdi.14090","article-title":"High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study","volume":"15","author":"Cheng","year":"2024","journal-title":"J Diabetes Investig"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2023.03.020","article-title":"Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials","volume":"373","author":"Stroes","year":"2023","journal-title":"Atherosclerosis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.885516","article-title":"Association between high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes mellitus","volume":"13","author":"Tang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003197","article-title":"Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study","volume":"11","author":"Lin","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2023-220760","article-title":"High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease","volume":"77","author":"Yang","year":"2023","journal-title":"J Epidemiol Community Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2023.08.019","article-title":"Systemic inflammation with high-sensitivity C-reactive protein and atherosclerotic plaque progression","volume":"17","author":"Bienstock","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1038\/s41598-024-63886-z","article-title":"The association between triglyceride glucose-body mass index and all-cause and cardiovascular mortality in diabetes patients: a retrospective study from NHANES database","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-022-01507-7","article-title":"Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure","volume":"21","author":"Huang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome","volume":"32","author":"Son","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1038\/s41598-024-66692-9","article-title":"Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis","volume":"14","author":"Wan","year":"2024","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.22-63","article-title":"Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance","volume":"72","author":"Ramdas Nayak","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","article-title":"TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients","volume":"21","author":"Zhao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s13018-023-04275-6","article-title":"Association between triglyceride-glucose index and bone mineral density in US adults: a cross sectional study","volume":"18","author":"Zhan","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12944-023-01857-5","article-title":"Association between triglyceride-glucose index and low-density lipoprotein particle size in korean obese adults","volume":"22","author":"Kim","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1186\/s12889-020-09901-0","article-title":"Assessing the routine-practice gap for home blood pressure monitoring among Chinese adults with hypertension","volume":"20","author":"Zuo","year":"2020","journal-title":"BMC Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"Jama"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.08.006","article-title":"Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression","volume":"32","author":"Itani","year":"2017","journal-title":"Sleep Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","article-title":"2018 chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of chinese guidelines for prevention and treatment of hypertension","volume":"16","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.04.001","article-title":"Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study","volume":"33","author":"Feng","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B31","article-title":"Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults","volume":"20","author":"Wen","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13098-023-01205-8","article-title":"Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey","volume":"15","author":"Zhang","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","author":"Laakso","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.07.008","article-title":"Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents","volume":"5","author":"Uetani","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","article-title":"The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13098-022-00927-5","article-title":"Association between the triglyceride-glucose (TyG) index and increased blood pressure in normotensive subjects: a population-based study","volume":"14","author":"Lee","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-020-01054-z","article-title":"Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome","volume":"19","author":"Wang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-021-01332-4","article-title":"Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents","volume":"20","author":"Zhu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-023-02001-4","article-title":"High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction","volume":"22","author":"Zhou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-019-0898-x","article-title":"Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study","volume":"18","author":"Zhao","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1038\/ncomms13151","article-title":"TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis","volume":"7","author":"Zysset","year":"2016","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1358863X14550542","article-title":"Design and utilization of macrophage and vascular smooth muscle cell co-culture systems in atherosclerotic cardiovascular disease investigation","volume":"19","author":"Zuniga","year":"2014","journal-title":"Vasc Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-022-01683-6","article-title":"Association between the triglyceride-glucose index and carotid plaque incidence: a longitudinal study","volume":"21","author":"Zhang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"20038","DOI":"10.1038\/s41598-024-70213-z","article-title":"The synergistic effect of triglyceride-glucose index and HbA1c on blood pressure control in patients with hypertension: a retrospective cohort study","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12933-022-01694-3","article-title":"Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-024-02313-z","article-title":"Dual-trajectory of TyG levels and lifestyle scores and their associations with ischemic stroke in a non-diabetic population: a cohort study","volume":"23","author":"Zhou","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-023-01967-5","article-title":"Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study","volume":"22","author":"Zheng","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-009-0026-2","article-title":"Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein","volume":"104","author":"Zimmermann","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02528.x","article-title":"Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study","volume":"5","author":"Zakai","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000164625.93129.64","article-title":"Elevated serum C-reactive protein levels and advanced atherosclerosis in youth","volume":"25","author":"Zieske","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24011","article-title":"C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases","volume":"53","author":"Xi","year":"2011","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1525","article-title":"Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents","volume":"31","author":"Vel\u00e1squez-Mieyer","year":"2008","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.302795","article-title":"Fc\u03b3 receptors and ligands and cardiovascular disease","volume":"116","author":"Tanigaki","year":"2015","journal-title":"Circ Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13589","article-title":"The combined effect of triglyceride-glucose index and high-sensitivity C-reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study","volume":"16","author":"Li","year":"2024","journal-title":"J Diabetes"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","article-title":"A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","article-title":"Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study","volume":"23","author":"Cui","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2021.07.009","article-title":"Association of triglyceride-glucose index and high-sensitivity C-reactive protein with asymptomatic intracranial arterial stenosis: A cross-sectional study","volume":"31","author":"Zhang","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.05.959","article-title":"Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults","volume":"235","author":"Zuliani","year":"2014","journal-title":"Atherosclerosis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12933-024-02435-4","article-title":"The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study","volume":"23","author":"Jiang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-023-01846-z","article-title":"Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12944-025-02441-9","article-title":"Association between Heavy metals and triglyceride-glucose-related index: a mediation analysis of inflammation indicators","volume":"24","author":"Hu","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S333","article-title":"Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes","author":"Davidson","year":"2009","journal-title":"Diabetes Care"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa009","article-title":"The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions","volume":"116","author":"Konst","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41387-024-00295-1","article-title":"The association of triglyceride-glucose index with major adverse cardiovascular and cerebrovascular events after acute myocardial infarction: a meta-analysis of cohort studies","volume":"14","author":"Liu","year":"2024","journal-title":"Nutr Diabetes"},{"key":"B70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6560498","DOI":"10.1155\/2019\/6560498","article-title":"Ethanol Extract of Leaves of Cassia siamea Lam Protects against Diabetes-Induced Insulin Resistance, Hepatic, and Endothelial Dysfunctions in ob\/ob Mice","volume":"2019","author":"Koffi","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.6.676","article-title":"Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin","volume":"101","author":"Kuboki","year":"2000","journal-title":"Circulation"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.02.003","article-title":"Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue","volume":"56","author":"Eringa","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/qjmed\/hcg134","article-title":"C-reactive protein and cardiovascular disease: new insights from an old molecule","volume":"96","author":"Hirschfield","year":"2003","journal-title":"Qjm"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05084-z","article-title":"SGLT2 inhibitors: how do they affect the cardiac cells","volume":"480","author":"Erdogan","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B77","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa183","article-title":"Effects of dapagliflozin in DAPA-HF according to background heart failure therapy","volume":"41","author":"Docherty","year":"2020","journal-title":"Eur Heart J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.15420\/cfr","article-title":"Glucagon-like peptide-1 receptor agonists in the context of pathophysiology of diverse heart failure with preserved ejection fraction phenotypes: potential benefits and mechanisms of action","volume":"10","author":"Bykova","year":"2024","journal-title":"Card Fail Rev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"H370","DOI":"10.1152\/ajpheart.00257.2024","article-title":"GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes","volume":"327","author":"Park","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1511319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:16:33Z","timestamp":1743466593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1511319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":81,"alternative-id":["10.3389\/fendo.2025.1511319"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1511319","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"1511319"}}